Evaluating the Effectiveness of an Adjunct Therapy in Dogs with Osteosarcoma
Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.
Displaying 22 - 28 of 44 Results
Establishing a Standard-of-Care Control Group for Osteosarcoma Treatment Studies
Researchers are studying a group of 80 dogs with osteosarcoma to generate comparison data for ongoing and future studies of new chemotherapeutic agents.
Finding New Treatment Targets for Canine Mammary Gland Cancer
Researchers will investigate a novel therapeutic target for mammary gland cancer in dogs.
Targeting a Genetic Mutation Associated with Canine Bladder Cancer
Researchers will explore drug treatments that target a genetic mutation associated with bladder cancer in dogs.
Determining the Prognostic Value of Identifying Genetic Mutations in Dogs with Lymphoma
Researchers will assess the value of a genetic prognostic tool to assist with treatment decisions for dogs with diffuse large B-cell lymphoma.
Measuring Chemotherapy Drug Resistance in Dogs with T-cell Lymphoma
Researchers will measure changes in circulating cancerous T-cells in dogs with lymphoma to gauge chemotherapy drug resistance and tailor treatments for individual patients with this aggressive and common cancer.
Predicting Chemotherapy Drug Response for Dogs with Bone Cancer
Researchers will assess how well specific chemotherapy drugs work as an adjunct therapy for dogs recovering from bone cancer surgery.